Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2a Study to Evaluate Safety, Tolerability, and Efficacy of PRCL-02 in Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT03614078 is registered in ClinicalTrials.gov with PRCL Research Inc. as lead sponsor.

NCT NCT03614078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03614078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2a Study to Evaluate Safety, Tolerability, and Efficacy of PRCL-02 in Patients With Moderate to Severe Chronic Plaque Psoriasis
Lead sponsor
PRCL Research Inc.
Phase
Phase 2
Overall status
Completed
Start date
September 25, 2018
Completion date
July 8, 2019
Enrollment
92 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis, psoriasis vulgaris